DECISION-Project’s Post

🌟 Exciting news from the DECISION-Project! The first patient has been enrolled at Hôpital Beaujon, Clichy, France in the COMBAT Trial! This EU-funded Phase II clinical trial will explore a novel combinatorial therapy with albumin and enoxaparin for decompensated cirrhosis. 🔊“We are excited to begin the COMBAT Trial and are hopeful that the combination of albumin and enoxaparin will offer a new therapeutic option for patients with decompensated cirrhosis. Our ultimate goal is to reduce mortality and improve quality of life for these patients.” - Prof. Dr Paolo Caraceni, Principal Investigator of the COMBAT Trial 🔊“The initiation of the COMBAT Trial is a testament to the hard work and dedication of our researchers and partners. We are grateful to the patients who are participating in this study and look forward to advancing our understanding of albumin and enoxaparin through this clinical trial." - Prof. Dr Pierre-Emmanuel Rautou, Scientific coordinator of DECISION 👉Read the full press release: https://lnkd.in/ez97vhyd